Citation of this article
Corresponding Author of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (4026)
All Articles published online
|
Oct 15, 2003 (publication date) through Mar 13, 2025
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Chen YX, Zhong XY, Qin YF, Bing W, He LZ. 15d-PGJ2 inhibits cell growth and induces apoptosis of MCG-803 human gastric cancer cell line. World J Gastroenterol 2003; 9(10): 2149-2153 [PMID: 14562367 DOI: 10.3748/wjg.v9.i10.2149] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v9/i10/2149.htm |
| Number | Citing Articles |
| 1 |
Qing Jia, Baozhen Li, Xiulian Wang, Yongfen Ma, Gaozhong Li. Comprehensive analysis of peroxisome proliferator-activated receptors to predict the drug resistance, immune microenvironment, and prognosis in stomach adenocarcinomas. PeerJ 2024; 12: e17082 doi: 10.7717/peerj.17082
|
| 2 |
Emily Yun-Chia Chang, Yi-Cheng Chang, Chia-Tung Shun, Yu-Wen Tien, Shu-Huei Tsai, Siow-Wey Hee, Ing-Jung Chen, Lee-Ming Chuang, Ajay Pratap Singh. Inhibition of Prostaglandin Reductase 2, a Putative Oncogene Overexpressed in Human Pancreatic Adenocarcinoma, Induces Oxidative Stress-Mediated Cell Death Involving xCT and CTH Gene Expressions through 15-Keto-PGE2. PLOS ONE 2016; 11(1): e0147390 doi: 10.1371/journal.pone.0147390
|
| 3 |
Ki Young Kim, Sung Soo Kim, Hyae Gyeong Cheon. Differential anti-proliferative actions of peroxisome proliferator-activated receptor-γ agonists in MCF-7 breast cancer cells. Biochemical Pharmacology 2006; 72(5): 530 doi: 10.1016/j.bcp.2006.05.009
|
| 4 |
Yasuhiro Yamamoto, Megumi Fujita, Hiromi Koma, Motohiro Yamamori, Tsutomu Nakamura, Noboru Okamura, Tatsurou Yagami. 15-Deoxy-Δ12,14-prostaglandin J2 enhanced the anti-tumor activity of camptothecin against renal cell carcinoma independently of topoisomerase-II and PPARγ pathways. Biochemical and Biophysical Research Communications 2011; 410(3): 563 doi: 10.1016/j.bbrc.2011.06.026
|
| 5 |
S.Y. Kim, M.S. Kim, M.K. Lee, J.S. Kim, H.K. Yi, S.Y. Nam, D.Y. Lee, P.H. Hwang. PPARγ induces growth inhibition and apoptosis through upregulation of insulin-like growth factor-binding protein-3 in gastric cancer cells. Brazilian Journal of Medical and Biological Research 2015; 48(3): 226 doi: 10.1590/1414-431x20144212
|
| 6 |
Jihan Youssef, Mostafa Badr. Peroxisome proliferator-activated receptors and cancer: challenges and opportunities. British Journal of Pharmacology 2011; 164(1): 68 doi: 10.1111/j.1476-5381.2011.01383.x
|
| 7 |
Zhi Yi Chen, Chi-Chuan Tseng. 15-Deoxy-Δ12,14 Prostaglandin J2 Up-Regulates Krüppel-Like Factor 4 Expression Independently of Peroxisome Proliferator-Activated Receptor γ by Activating the Mitogen-Activated Protein Kinase Kinase/Extracellular Signal-Regulated Kinase Signal Transduction Pathway in HT-29 Colon Cancer Cells. Molecular Pharmacology 2005; 68(5): 1203 doi: 10.1124/mol.105.014944
|
| 8 |
Mei Ming, Jie-Ping Yu, Xiang-Zhi Meng, Yan-Hong Zhou, Hong-Gang Yu, He-Sheng Luo. Effect of ligand troglitazone on peroxisome proliferator-activated receptor γ expression and cellular growth in human colon cancer cells. World Journal of Gastroenterology 2006; 12(45): 7263-7270 doi: 10.3748/wjg.v12.i45.7263
|
| 9 |
Valerio Ciccone, Martina Monti, Enrico Monzani, Luigi Casella, Lucia Morbidelli. The metal-nonoate Ni(SalPipNONO) inhibitsin vitrotumor growth, invasiveness and angiogenesis. Oncotarget 2018; 9(17): 13353 doi: 10.18632/oncotarget.24350
|
| 10 |
Jun Yu, Wai K. Leung, Jie Chen, Matthias P.A. Ebert, Peter Malfertheiner, Joseph J.Y. Sung. Expression of peroxisome proliferator-activated receptor δ in human gastric cancer and its response to specific COX-2 inhibitor. Cancer Letters 2005; 223(1): 11 doi: 10.1016/j.canlet.2004.09.052
|
| 11 |
SHIMENG ZHANG, FEI LIU, XINRU MAO, JINLAN HUANG, JUNYAO YANG, XIAOMAO YIN, LIJUAN WU, LEI ZHENG, QIAN WANG. Elevation of miR-27b by HPV16 E7 inhibits PPARγ expression and promotes proliferation and invasion in cervical carcinoma cells. International Journal of Oncology 2015; 47(5): 1759 doi: 10.3892/ijo.2015.3162
|
| 12 |
P. Sertznig, M. Seifert, W. Tilgen, J. Reichrath. Present concepts and future outlook: Function of peroxisome proliferator‐activated receptors (PPARs) for pathogenesis, progression, and therapy of cancer. Journal of Cellular Physiology 2007; 212(1): 1 doi: 10.1002/jcp.20998
|
| 13 |
Jie Lu, Kazuhiro Imamura, Sachiyo Nomura, Ken-ichi Mafune, Atsushi Nakajima, Takashi Kadowaki, Naoto Kubota, Yasuo Terauchi, Genichiro Ishii, Atsushi Ochiai, Hiroyasu Esumi, Michio Kaminishi. Chemopreventive Effect of Peroxisome Proliferator–Activated Receptor γ on Gastric Carcinogenesis in Mice. Cancer Research 2005; 65(11): 4769 doi: 10.1158/0008-5472.CAN-04-2293
|
| 14 |
Sangeeta Ballav, Bini Biswas, Vishal Kumar Sahu, Amit Ranjan, Soumya Basu. PPAR-γ Partial Agonists in Disease-Fate Decision with Special Reference to Cancer. Cells 2022; 11(20): 3215 doi: 10.3390/cells11203215
|
| 15 |
Kyoko Ota, Kiyoshi Ito, Takashi Suzuki, Sumika Saito, Mitsutoshi Tamura, Shin-ichi Hayashi, Kunihiro Okamura, Hironobu Sasano, Nobuo Yaegashi. Peroxisome Proliferator-Activated Receptor γ and Growth Inhibition by Its Ligands in Uterine Endometrial Carcinoma. Clinical Cancer Research 2006; 12(14): 4200 doi: 10.1158/1078-0432.CCR-05-1833
|
| 16 |
Anne R. Diers, Brian P. Dranka, Karina C. Ricart, Joo Yeun Oh, Michelle S. Johnson, Fen Zhou, Manuel A. Pallero, Thomas M. Bodenstine, Joanne E. Murphy-Ullrich, Danny R. Welch, Aimee Landar. Modulation of mammary cancer cell migration by 15-deoxy-Δ12,14-prostaglandin J2: implications for anti-metastatic therapy. Biochemical Journal 2010; 430(1): 69 doi: 10.1042/BJ20091193
|
| 17 |
Ulrika Smedh, Annika Gustafsson, Hans Axelsson, Christian Cahlin, Christina Lönnroth, Kent Lundholm. From Molecular to Modular Tumor Therapy. 2010; : 313 doi: 10.1007/978-90-481-9531-2_15
|
| 18 |
Bin Zhang, Qingli Bie, Peipei Wu, Jie Zhang, Benshuai You, Hui Shi, Hui Qian, Wenrong Xu. PGD2/PTGDR2 Signaling Restricts the Self-Renewal and Tumorigenesis of Gastric Cancer. Stem Cells 2018; 36(7): 990 doi: 10.1002/stem.2821
|
| 19 |
Su-Jung Kim, Nam-Chul Cho, Young-Il Hahn, Seong Hoon Kim, Xizhu Fang, Young-Joon Surh. STAT3 as a Potential Target for Tumor Suppressive Effects of 15-Deoxy-δ12,14-prostaglandin J2 in Triple Negative Breast Cancer. Journal of Cancer Prevention 2021; 26(3): 207 doi: 10.15430/JCP.2021.26.3.207
|
| 20 |
YASUHIRO YAMAMOTO, HIROMI KOMA, HIROKI HIRAMATSU, MISA ABE, KAZUNORI MURAKAMI, ASAKO OHYA, TATSUROU YAGAMI. Treatment of etoposide combined with 15-deoxy-Δ12,14-prostaglandin J2 exerted synergistic antitumor effects against renal cell carcinoma via peroxisome proliferator-activated receptor-γ-independent pathways. Molecular and Clinical Oncology 2014; 2(2): 292 doi: 10.3892/mco.2013.234
|
| 21 |
Sung-Won Shin, Chi-Yeon Seo, Hoon Han, Jin-Yeong Han, Jin-Sook Jeong, Jong-Young Kwak, Joo-In Park. 15d-PGJ2 Induces Apoptosis by Reactive Oxygen Species–mediated Inactivation of Akt in Leukemia and Colorectal Cancer Cells and Shows In vivo Antitumor Activity. Clinical Cancer Research 2009; 15(17): 5414 doi: 10.1158/1078-0432.CCR-08-3101
|
| 22 |
Emily Yun-Chia Chang, Shu-Huei Tsai, Chia-Tung Shun, Siow-Wey Hee, Yi-Cheng Chang, Yun-Chih Tsai, Jaw-Shiun Tsai, Hsian-Ju Chen, Jia-Wei Chou, Shih-Yao Lin, Lee-Ming Chuang. Prostaglandin Reductase 2 Modulates ROS-Mediated Cell Death and Tumor Transformation of Gastric Cancer Cells and Is Associated with Higher Mortality in Gastric Cancer Patients. The American Journal of Pathology 2012; 181(4): 1316 doi: 10.1016/j.ajpath.2012.07.006
|
| 23 |
Annika Gustafsson, Elisabeth Hansson, Ulf Kressner, Svante Nordgren, Marianne Andersson, Wenhua Wang, Christina Lönnroth, Kent Lundholm. EP1–4 subtype, COX and PPARγ receptor expression in colorectal cancer in prediction of disease‐specific mortality. International Journal of Cancer 2007; 121(2): 232 doi: 10.1002/ijc.22582
|
| 24 |
Swarang Sachin Pundlik, Alok Barik, Ashwin Venkateshvaran, Snehasudha Subhadarshini Sahoo, Mahapatra Anshuman Jaysingh, Raviswamy GH Math, Heera Lal, Maroof Athar Hashmi, Arvind Ramanathan. Senescent cells inhibit mouse myoblast differentiation via the SASP-lipid 15d-PGJ2 mediated modification and control of HRas. eLife 2024; 13 doi: 10.7554/eLife.95229.3
|
| 25 |
Mary-Clare Cathcart, Kenneth J. O'Byrne, John V. Reynolds, Jacintha O'Sullivan, Graham P. Pidgeon. COX-derived prostanoid pathways in gastrointestinal cancer development and progression: Novel targets for prevention and intervention. Biochimica et Biophysica Acta (BBA) - Reviews on Cancer 2012; 1825(1): 49 doi: 10.1016/j.bbcan.2011.09.004
|
| 26 |
Guang Jia, Yi-Qun Gu, Kung-Tung Chen, You-Yong Lu, Lei Yan, Jian-Ling Wang, Ya-Ping Su, J. C. Gaston Wu. Protective role of metallothionein (I/II) against pathological damage and apoptosis induced by dimethylarsinic acid. World Journal of Gastroenterology 2004; 10(1): 91-95 doi: 10.3748/wjg.v10.i1.91
|
| 27 |
Takako Kawakita, Nisimura Masato, Eri Takiguchi, Akiko Abe, Minoru Irahara. Cytotoxic effects of 15-deoxy-Δ12,14-prostaglandin J2 alone and in combination with dasatinib against uterine sarcoma in vitro. Experimental and Therapeutic Medicine 2017; 13(6): 2939 doi: 10.3892/etm.2017.4346
|
| 28 |
Hye-Kyung Na, Hongkyung Yang, Young-Joon Surh. 15-Deoxy-Δ12,14-prostaglandin J2 Induces Apoptosis in Ha-ras-transformed Human Breast Epithelial Cells by Targeting IκB kinase–NF-κB Signaling. Journal of Cancer Prevention 2020; 25(2): 100 doi: 10.15430/JCP.2020.25.2.100
|
| 29 |
Jong-Min Lee, Sung Soo Kim, Young-Seok Cho. The Role of PPARγinHelicobacter pyloriInfection and Gastric Carcinogenesis. PPAR Research 2012; 2012: 1 doi: 10.1155/2012/687570
|
| 30 |
Jihan A. Youssef, Mostafa Z. Badr. Peroxisome Proliferator-Activated Receptors. 2013; : 33 doi: 10.1007/978-1-62703-420-3_5
|
| 31 |
ShouWei Han, Jesse Roman. Suppression of prostaglandin E2 receptor subtype EP2 by PPARγ ligands inhibits human lung carcinoma cell growth. Biochemical and Biophysical Research Communications 2004; 314(4): 1093 doi: 10.1016/j.bbrc.2004.01.007
|
| 32 |
Kyoung-Jin Kim, Han-Gyu Park, Cheol-Hwan Hwang, Da-Hee Ann, Won-Suk Song, Kwon-Young Choi, Yung-Hun Yang, SangYoun Park, Yun-Gon Kim. Quantitative targeted metabolomics for 15d-deoxy-Δ12, 14-PGJ2 (15d-PGJ2) by MALDI-MS. Biotechnology and Bioprocess Engineering 2017; 22(1): 100 doi: 10.1007/s12257-016-0558-x
|
| 33 |
Chueh-Chuan Yen, Chung-Der Hsiao, Wei-Ming Chen, Yao-Shan Wen, Yung-Chan Lin, Ting-Wei Chang, Fang-Yi Yao, Shih-Chieh Hung, Jir-You Wang, Jen-Hwey Chiu, Hsei-Wei Wang, Chi-Hung Lin, Tain-Hsiung Chen, Paul Chih-Hsueh Chen, Chien-Lin Liu, Cheng-Hwai Tzeng, Jonathan A. Fletcher. Cytotoxic effects of 15d-PGJ2 against osteosarcoma through ROS-mediated AKT and cell cycle inhibition. Oncotarget 2014; 5(3): 716 doi: 10.18632/oncotarget.1704
|